Sentromer DNA Technologies Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

Sentromer DNA Technologies General Information

Description

Provide of DNA extraction services. The company offers molecular diagnostic testing, DNA extraction, PCR assay development as well as Oligonucleotide synthesis service.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Other Industries
Other Healthcare
Primary Office
  • Sarıyer Cad. 117B/12
  • ABC Plaza
  • 34460 Istanbul
  • Turkey
+90 (0212) 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sentromer DNA Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 29-Jan-2015 Completed Startup
To view Sentromer DNA Technologies’s complete valuation and funding history, request access »

Sentromer DNA Technologies Executive Team (1)

Name Title Board Seat Contact Info
Pinar Akalin Ph.D Owner, Founder & Managing Director
To view Sentromer DNA Technologies’s complete executive team members history, request access »

Sentromer DNA Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sentromer DNA Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ITU ARI Teknokent Accelerator/Incubator 000 0000 000000 0
Sente Foundry Corporate Venture Capital 000 0000 000000 0
To view Sentromer DNA Technologies’s complete investors history, request access »